Results for: oncology+products

Pfizer $33 Billion Question Remains After Teva, Actavis Feelers

EU puts conditions on deals involving Novartis, GSK

EU clears plans by drugmakers GSK and Novartis to trade assets

Pfizer’s Hunt Said to Have Included Rebuffed Teva Approach

Roche Forecasts Higher Earnings as 2014 EPS Misses Estimates

Bristol-Myers 2015 Sales Forecast Hit by Dollar’s Strength

Ziopharm takes bigger loss as research costs grow

Chavez back in Venezuela, stirs succession talk

Cancer costs EU $170 bln annually

Cold caps tested to prevent hair loss during chemo

Roche's $8 billion InterMune buy not a signal for more big deals

New breast cancer drugs boost sales at Roche

Pfizer earnings drop less than expected

Deal fever hits global pharma sector

Pfizer sales way off mark as company pursues AstraZeneca

AstraZeneca rejects sweetened Pfizer takeover bid

Google researching use of color in business